Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 11 03 2022
accepted: 22 03 2022
entrez: 6 5 2022
pubmed: 7 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

Schnitzler syndrome is a rare adult-onset acquired autoinflammatory disorder typically characterized by chronic urticarial rash and immunoglobulin M (IgM) (rarely IgG) monoclonal gammopathy. Its clinical symptoms usually respond well to interleukin-1 blockade therapy, which, however, does not impact the underlying monoclonal gammopathy. Herein, we described a female patient who presented with urticarial rash, recurrent fevers, and fatigue for 7 years. Laboratory investigations revealed IgMκ monoclonal protein and

Identifiants

pubmed: 35514998
doi: 10.3389/fimmu.2022.894464
pmc: PMC9065412
doi:

Substances chimiques

Antibodies, Monoclonal 0
Piperidines 0
ibrutinib 1X70OSD4VX
Adenine JAC85A2161

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

894464

Informations de copyright

Copyright © 2022 Huang, Wang, Yu, Mao, Wang, Li and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Arthritis Res Ther. 2020 Nov 18;22(1):272
pubmed: 33208192
J Allergy Clin Immunol. 2017 Oct;140(4):1054-1067.e10
pubmed: 28216434
J Allergy Clin Immunol. 2008 Jan;121(1):260-2
pubmed: 17936890
J Oncol Pract. 2018 Jun;14(6):387-388
pubmed: 29558252
Arthritis Rheumatol. 2019 Dec;71(12):2121-2125
pubmed: 31268627
J Clin Immunol. 2021 Oct;41(7):1706-1707
pubmed: 34313913
Semin Arthritis Rheum. 2007 Dec;37(3):137-48
pubmed: 17586002
Blood. 2018 Mar 1;131(9):974-981
pubmed: 29284595
Blood. 2019 Mar 7;133(10):1039-1048
pubmed: 30670444
Ann Rheum Dis. 2013 Oct;72(10):1634-8
pubmed: 23087179
Blood. 2018 Oct 4;132(14):1478-1485
pubmed: 30012636
Drugs. 2018 Nov;78(16):1653-1663
pubmed: 30390220
J Clin Immunol. 2021 Aug;41(6):1380-1383
pubmed: 33871787
Rheumatology (Oxford). 2019 Nov 1;58(Suppl 6):vi31-vi43
pubmed: 31769858
J Dermatol. 2021 Nov;48(11):1789-1792
pubmed: 34435697

Auteurs

Yuehua Huang (Y)

Department of Hematology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Yanying Wang (Y)

Department of Hematology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Fan Yu (F)

Department of Hematology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Xuehan Mao (X)

Department of Hematology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Bianhong Wang (B)

Department of Hematology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Jingxian Li (J)

Department of Hematology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Lihong Li (L)

Department of Hematology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH